Publication|Articles|June 20, 2025
- Pharmaceutical Executive: June 2025
- Volume 45
- Issue 5
Pharmaceutical Executive: June 2025 Interactive Digital Edition
View the Pharmaceutical Executive June 2025 issue in an interactive format.
Advertisement
Articles in this issue
about 1 year ago
Role Eye-Openerabout 1 year ago
2025 Pharm Exec Top 50 Companiesabout 1 year ago
Beyond the Pharma 50: Key Data Trends and Highlightsabout 1 year ago
Jim Weiss: Molded in Mentorshipabout 1 year ago
Reinventing Pharma Sales Force Effectivenessabout 1 year ago
Earned Media and PBMs: Proactive Pathways for Image Boostabout 1 year ago
Rethinking Audience Modeling: AI, Regulations, & Moreabout 1 year ago
Transforming Healthcare: Beyond Buzzwords to Purposeful ChangeAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
Trump Administration Preparing New Round of Medicaid Drug-Pricing Deals: Report
2
M&A Roundup: DualityBio & Genentech Enter Partnership to Develop Next Generation ADC’s, Teva Bids to Acquire Igalmi from BioXcel
3
Pharmaceutical Executive Daily: DualityBio and Teva Strike Major Biopharma Deals
4
FDA Approves Lisraya for Adults with Dermatomyositis, Bixlenvo for Virologically Suppressed Adults with HIV, Mounjaro to Reduce MACE in Adults with Type 2 Diabetes
5